Momordica charantia for type 2 diabetes mellitus

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Ooi, Cheow Peng ^a   Yassin, Zaitun ^a   Hamid, Tengku Aizan ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOLYTIC ENZYME; GLYCOSYLATED HEMOGLOBIN; HERBACEOUS AGENT; INSULIN; METFORMIN; MOMORDICA CHARANTIA EXTRACT; ORAL ANTIDIABETIC AGENT; PLACEBO; ROSIGLITAZONE; SULFONYLUREA; TRIACYLGLYCEROL LIPASE;

ANTIMICROBIAL ACTIVITY; BODY MASS; BRAIN PROTECTION; CARBOHYDRATE METABOLISM; CLINICAL TRIAL; CONVULSION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERLIPIDEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC COMA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MOMORDICA CHARANTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; REVIEW; RISK ASSESSMENT; SELF CARE; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; WOUND HEALING;

EID: 70349120964     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007845     Document Type: Review

References (65)

1. Abd El Sattar El Batran S, El-Gengaihi SE, et al. Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats. J Ethnopharmacol 2006;108(2):236-242. (Pubitemid 44635038)
2. Abegunde DO, Mathers CD, et al. The burden and costs of chronic diseases in low-income and middle-income countries. The Lancet 2007;370(9603):1929-1938.
3. American Diabetes Association. Report on the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20 Suppl 1:S5-20.
4. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1999;22 Suppl 1:S5-19.
5. Ahmad N, Hassan MR, Halder H, Bennoor KS. Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serumglucose levels in NIDDM patients. Bangladesh Med Res Counc Bull 1999;25 (1):11-13.
6. Ahmed I, Adeghate E, Sharma AK, et al. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res Clin Pract 1998;40(3):145-151. (Pubitemid 28332875)
7. Ahmed I, Lakhani MS, et al. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2001;51(3):155-161. (Pubitemid 32223909)
8. Ahmed I, Adeghate E, et al. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat. Mol Cell Biochem 2004;261(1-2): 63-70. (Pubitemid 39004517)
9. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care, 1989;12(8):553-564. (Pubitemid 19214828)
10. Bantle JP, Wylie-Rosett J, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008;31(Suppl 1):S61-78. (Pubitemid 46395921)
11. Bourinbaiar AS, Lee-Huang S. The activity of plant-derived antiretroviral proteinsMAP30 and GAP31 against herpes simplex virus in vitro. Biochem Biophys Res Commun 1996;219(3):923-929. (Pubitemid 26106780)
12. Braca A, Siciliano T, et al. Chemical composition and antimicrobial activity of Momordica charantia seed essential oil. Fitoterapia 2008; 79(2):123-125.
13. Chan WY, Tam PP, et al. The termination of early pregnancy in the mouse by beta-momorcharin. Contraception 1984;29(1):91-100. (Pubitemid 14133616)
14. Chan WY, Tam PP, et al. The inhibitory effects of beta-momorcharin on endometrial cells in themouse. Contraception 1985;31(1):83-90. (Pubitemid 15058106)
15. Chan WY, Tam PP, et al. Effects of momorcharins on the mouse embryo at the early organogenesis stage. Contraception 1986;34(5): 537-544.
16. Chaturvedi P. Role of Momordica charantia in maintaining the normal levels of lipids and glucose in diabetic rats fed a high-fat and lowcarbohydrate diet. Br J Biomed Sci, 62(3), 124-126. 2005;62(3): 124-126. (Pubitemid 41603067)
17. Cockram CS. Diabetes mellitus: perspective from the Asia-Pacific region. Diabetes Res Clin Pract 2000;50(Suppl 2):S3-7.
18. Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37-46.
19. Cummings E, Hundal HS, Wackerhage H, et al. Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes. Mol Cell Biochem 2004;26(1-2):99-104. (Pubitemid 39004522)
20. Cunnick JE, Sakamoto K, et al. Induction of tumor cytotoxic immune cells using a protein from the bitter melon (Momordica charantia). Cell Immunol 1990;126(2):278-289. (Pubitemid 20107640)
21. Dutta PK, Chakravarty AK, et al. Vicine, a favism-inducing toxin from Momordica charantia L., seeds. Indian J. Chem 1981;20(B): 669-671.
22. Fernandes NP, Lagishetty CV, et al. An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract. BMC Complement Altern Med 2007; 24(7):29.
23. Frame AD, Rios-Olivares E, et al. Plants from Puerto Rico with anti-Mycobacterium tuberculosis properties. P R Health Sci J 1998;17 (3):243-252.
24. Genser D. Food and drug interaction: consequences for the nutrition/health status. Ann Nutr Metab 2008;52(Suppl 1):29-32.
25. Grover JK, Rathi SS, et al. Amelioration of experimental diabetic neuropathy and gastropathy in rats following oral administration of plant (Eugenia jambolana, Mucuna pruriens and Tinospora cordifolia) extracts. Indian J Exp Biol 2002;40(3):273-276.
26. Grover JK, Yadav S, et al. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 2002;81(1):81-100. (Pubitemid 34518472)
27. Higgins JPT, Thompson SG. Quantifying heterogeneity in a metaanalysis. Statistics in medicine 2002;21:1539-1558
28. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-560
29. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochranehandbook.org..
30. Hulin A, Wavelet M, et al. Intoxication aigue par Momordica charantia (sorrossi). A propos de deux cas. Medecine dAfrique Noir, 1988a;35(9):671-674.
31. Hulin A, Wavelet M, et al. Intoxication aigue par Momordica charantia (sorrossi). A propos de deux cas. Semaine des hospitaux 1988b; 64(44):2847-2848. (Pubitemid 18275667)
32. Khanna P, Jain SC, Panagariya A, Dixit VP. Hypoglycemic activity of polypeptide-p from a plant source. J Nat Prod 1981;44(6):648-655.
33. Kumar GS, Shetty AK, Salimath PV. Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats. J Ethnopharmacol 2008;115(2):276-283.
34. Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ 2006;333:597-600.
35. Leatherdale BA, Panesar RK, Singh G, et al. Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J (Clin Res Ed) 1981;282(6279):1823-1824. (Pubitemid 11047735)
36. Lee CM, Huxley RR, et al. Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions. Asia Pac J Clin Nutr 2007;16(1):187-192.
37. Li WL, Zheng HC, et al. Natural medicines used in the traditional Chinesemedical systemfor therapy of diabetesmellitus. J Ethnopharmacol 2004;92(1):1-21.
38. Miura T, Itoh Y, Iwamoto N, et al. Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice. Biol Pharm Bull 2004;27(2):248-250. (Pubitemid 41694711)
39. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354(9193):1896- 1900
40. Monnier VM, Mustata GT, et al. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution". Ann N Y Acad Sci 2005;1043:533-544. [: DOI: 10.1196/annals.1333.061 ]
41. Mukherjee PK, Maiti K, et al. Leads from Indian medicinal plants with hypoglycemic potentials.. J Ethnopharmacol 2006;106.(1):1-28. (Pubitemid 44255720)
42. Nivitabishekam SN, Asad M, et al. Pharmacodynamic interaction of Momordica charantia with rosiglitazone in rats. Chem Biol Interact 2008;Oct 15([Epub ahead of print]):doi: 10.1016/j.cbi.2008.09.034.
43. Ogata F, Miyata T, et al. Purification and amino acid sequence of a bitter gourd inhibitor against an acidic amino acid-specific endopeptidase of Streptomyces griseus. J Biol Chem 1991;266(25):16715-16721. (Pubitemid 21907858)
44. Oishi Y, SakamotoT, et al. Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction. Biosci Biotechnol Biochem 2007;71(3):735-740.
45. Ojewole JA, Adewole SO, et al. Hypoglycaemic and hypotensive effects of Momordica charantia Linn (Cucurbitaceae) whole-plant aqueous extract in rats. Cardiovasc J S Afr 2006;17(5):227-232. (Pubitemid 46089124)
46. Omoregbe RE, Ikuebe OM, et al. Antimicrobial activity of some medicinal plants extracts on Escherichia coli, Salmonella paratyphi and Shigella dysenteriae. Afr J Med Med Sci 1996;25(4):373-375.
47. Rathi SS, Grover JK, Vats V. The effect ofMomordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytother Res 2002;16(3):236-243. (Pubitemid 34534949)
48. Rathi SS, Grover JK, et al. Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts. Phytother Res 2002;16 (8):774-777.
49. Rotshteyn Y, Zito SW. Application of modified in vitro screening procedure for identifying herbals possessing sulfonylurea-like activity. J Ethnopharmacol 2004;93(2-3):337-344. (Pubitemid 38962426)
50. Selvin E, Coresh J, et al. The Burden and Treatment of Diabetes in Elderly Individuals in the US. Diabetes Care 2006;29(11):2415-2419. (Pubitemid 44912245)
51. Shetty AK, Kumar GS, Sambaiah K, Salimath PV. Bitter gourd (Momordica charantia) modulates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats. Mol Nutr Food Res 2005;49(8):791-796. (Pubitemid 41188588)
52. Siemonsma J, Piluek K. Plants resources of South-East Asia [electronic resource]. World biodiversity database CD-ROM series. Vol. Vegetables, Paris: UNESCO-Publishing, 1997.
53. Singh N, Gupta M (2007). Regeneration of beta cells in islets of Langerhans of pancreas of alloxan diabetic rats by acetone extract of Momordica charantia (Linn.) (bitter gourd) fruits. Indian J Exp Biol 2007;45(12):1055- 1062.
54. Srivastava Y, Venkatakrishna-Bhatt H, et al. Retardation of retinopathy by Momordica charantia L. (bitter gourd) fruit extract in alloxan diabetic rats. Indian J Exp Biol 1987;25(8):571-572.
55. Srivastava Y. Antidiabetic and adaptogenic properties of Momordica charantia extract: an experimental and clinical evaluation. Phytother Res, 1993;7(4):285-289. (Pubitemid 23233627)
56. Sterne JAC, Egger M, Davey Smith G. Investigating and dealing with publication and other biases. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care; Meta-analysis in Context. London: BMJ Publishing Group, 2001:189-208.
57. Tongia A, Tongia SK, et al. Phytochemical determination and extraction of Momordica charantia fruit and its hypoglycemic potentiation of oral hypoglycemic drugs in diabetes mellitus (NIDDM). Indian J Physiol Pharmacol 2004;48(2):241-244. (Pubitemid 38436928)
58. Mehta Z, Cull C, et al. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). UK Prospective Diabetes Study Group. Diabetes Care 1999;22(7):1125-1136. (Pubitemid 29293966)
59. Waidmann T, Liu K. Disability trends among elderly persons and implications for the future. The Journals of Gerontology; B Social Sciences 2000;55B(5):S298-S307. (Pubitemid 32009037)
60. Welihinda J, Karunanayake EH, Sheriff MH, Jayasinghe K. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol 1986;17(3):277-282. (Pubitemid 17209188)
61. WHO Expert Committee on Diabetes Mellitus. Second report. Technical Report Series 646. Geneva. WHO, 1980.
62. WHO Expert Committee on Diabetes Mellitus. World Health Organization, 1985. Technical Report Series 727.
63. Alberti KM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its compliactions. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine 1998;15:539-553
64. Wild S, Roglic G, et al. Global prevalenceof diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5): 1047-1053.
65. Yesilada E, Gurbuz I, et al. Screening of Turkish anti-ulcerogenic folk remedies for anti-Helicobacter pylori activity. J Ethnopharmacol 1999;66(3):289-293. (Pubitemid 29287197)